Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wayne Tam

Showing results (81-90 of 140) with videos related to

Pageof 14
Sort By:
Haematologica|May 13, 2017
Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified and reactive idiopathic hypereosinophilic syndromeSa A Wang, Robert P Hasserjian, Wayne Tam, et al.
NPJ Genomic Medicine|August 8, 2017
Development and validation of a whole-exome sequencing test for simultaneous detection of point mutations, indels and copy-number alterations for precision cancer careHanna Rennert, Kenneth Eng, Tuo Zhang, et al.
The Journal of Experimental Medicine|June 11, 2014
Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapyElisa Oricchio, Giovanni Ciriello, Man Jiang, et al.
Frontiers in Oncology|September 16, 2021
Comparison of Multiple Clinical Testing Modalities for Assessment of NPM1-Mutant AMLAmanda Lopez, Sanjay Patel, Julia T Geyer, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 8, 2018
Hematopoietic neoplasms with 9p24/JAK2 rearrangement: a multicenter studyGuilin Tang, John Kennedy Sydney Sir Philip, Olga Weinberg, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 23, 2020
Chronic myeloid neoplasms harboring concomitant mutations in myeloproliferative neoplasm driver genes (JAK2/MPL/CALR) and SF3B1Chi Young Ok, Kevin T Trowell, Kyle G Parker, et al.
American Journal of Hematology|November 23, 2024
Acute Leukemias of Ambiguous Lineage With MDS-Associated Mutations Show Similar Prognosis Compared to Acute Myeloid Leukemia With MDS-Associated Mutations: A Study From the Bone Marrow Pathology GroupTimothy J Kirtek, Weina Chen, Jaryse C Harris, et al.
Blood|January 20, 2018
Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AMLRonan T Swords, Steven Coutre, Michael B Maris, et al.
American Journal of Hematology|October 18, 2025
Acute Leukemias of Ambiguous Lineage With RUNX1 Mutations Show Similar Prognosis Compared to Acute Myeloid Leukemia With RUNX1 Mutations: A Study From the Bone Marrow Pathology GroupTimothy J Kirtek, Weina Chen, Jaryse C Harris, et al.
Haematologica|November 20, 2023
<i>STAT5B</i> mutations in myeloid neoplasms differ by disease subtypes but characterize a subset of chronic myeloid neoplasms with eosinophilia and/or basophiliaC Cameron Yin, Wayne Tam, Serena M Walker, et al.
Pageof 14

Showing results (81-90 of 140) with videos related to

Sort By:
Pageof 14
Haematologica|May 13, 2017
Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified and reactive idiopathic hypereosinophilic syndromeSa A Wang, Robert P Hasserjian, Wayne Tam, et al.
NPJ Genomic Medicine|August 8, 2017
Development and validation of a whole-exome sequencing test for simultaneous detection of point mutations, indels and copy-number alterations for precision cancer careHanna Rennert, Kenneth Eng, Tuo Zhang, et al.
The Journal of Experimental Medicine|June 11, 2014
Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapyElisa Oricchio, Giovanni Ciriello, Man Jiang, et al.
Frontiers in Oncology|September 16, 2021
Comparison of Multiple Clinical Testing Modalities for Assessment of NPM1-Mutant AMLAmanda Lopez, Sanjay Patel, Julia T Geyer, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 8, 2018
Hematopoietic neoplasms with 9p24/JAK2 rearrangement: a multicenter studyGuilin Tang, John Kennedy Sydney Sir Philip, Olga Weinberg, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 23, 2020
Chronic myeloid neoplasms harboring concomitant mutations in myeloproliferative neoplasm driver genes (JAK2/MPL/CALR) and SF3B1Chi Young Ok, Kevin T Trowell, Kyle G Parker, et al.
American Journal of Hematology|November 23, 2024
Acute Leukemias of Ambiguous Lineage With MDS-Associated Mutations Show Similar Prognosis Compared to Acute Myeloid Leukemia With MDS-Associated Mutations: A Study From the Bone Marrow Pathology GroupTimothy J Kirtek, Weina Chen, Jaryse C Harris, et al.
Blood|January 20, 2018
Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AMLRonan T Swords, Steven Coutre, Michael B Maris, et al.
American Journal of Hematology|October 18, 2025
Acute Leukemias of Ambiguous Lineage With RUNX1 Mutations Show Similar Prognosis Compared to Acute Myeloid Leukemia With RUNX1 Mutations: A Study From the Bone Marrow Pathology GroupTimothy J Kirtek, Weina Chen, Jaryse C Harris, et al.
Haematologica|November 20, 2023
<i>STAT5B</i> mutations in myeloid neoplasms differ by disease subtypes but characterize a subset of chronic myeloid neoplasms with eosinophilia and/or basophiliaC Cameron Yin, Wayne Tam, Serena M Walker, et al.
Pageof 14